Tablo is a registered trademark of Outset Medical, Inc. Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at. Participants are encouraged to register more than 15 minutes before the start of the call. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Those interested in listening to the conference call may do so by registering online. The conference call will begin at 2:00 pm Pacific Time ( 5:00 pm Eastern Time) on Wednesday, May 3, 2023. On the same day, at 2:00 pm Pacific Time ( 5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2023 after the close of trading on Wednesday, May 3, 2023.
0 kommentar(er)
